Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study

Not Applicable

• Conditions: Hematologic Malignancy

• Registration Number: NCT00156858
• Lead Sponsor: Alberta Health services

Brief Summary

A study of pharmacokinetics of daily intravenous busulfan

Detailed Description

A study of pharmacokinetics of daily intravenous busulfan

Study Timeline

• Study Start: 1998-01
• Study First Submitted: 2005-09-08
• Study First Submitted QC: 2005-09-08
• Study First Posted: 2005-09-12
• Study Completion: 2010-12
• Status Verified: 2011-09
• Last Update Submitted: 2012-01-18
• Last Update Posted: 2012-01-19

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• patients undergoing transplantation

Exclusion Criteria

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
pharmacokinetic data

Trial Locations

Locations (1)

Tom Baker Cancer Centre; 🇨🇦 Calgary, Alberta, Canada